<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2022</year>
	<month>10</month>
	<day>26</day>
</pubdate>
<volume>23</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>36452188</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Frequency, Risk Factors, and Pregnancy Outcomes in Cases with Placenta Accreta Spectrum Disorder: A Case-Control Study</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Placenta accreta spectrum (PAS) disorder is an important life-threatening problem. The purpose of the current study was to determine the frequency, risk factors, and pregnancy outcomes of PAS in our population.&lt;br /&gt;
Methods: This is a case-control study using the data from a main tertiary referral university hospital in Ahvaz, southwest of Iran. The sample included 187 cases diagnosed with placenta accreta spectrum from 2015 to 2019 and 552 controls without PAS. A multivariable logistic regression model was used to find independent risk factors with 95% confidence interval. Pregnancy outcomes were evaluated using chi-square, t-test, and Mann-Whitney U test and p&amp;lt;0.05 were considered statistically significant.&lt;br /&gt;
Results: The frequency of PAS during the study period was 3.7/1000 deliveries (0.37%). It was found that multiparity (&amp;ge;3 deliveries, OR=2.05: 95%CI:1.21-3.47) and multigravidity (&amp;ge;3 deliveries, OR=2.98: 95%CI:1.55-5.72), prior cesarean delivery (OR=52.55: 95%CI:19.73-139.96), and placenta previa (OR=27.48: 95%CI:9.62-78.5) are the independent risk factors of PAS. Complications and morbidity associated with PAS included hysterectomy (60.4% &lt;em&gt;vs. &lt;/em&gt;0.7%, p&amp;lt;0.001), cystostomy (24.1% &lt;em&gt;vs.&lt;/em&gt; 0.2%, p&amp;lt;0.001), the need for blood transfusion (73.7% &lt;em&gt;vs.&lt;/em&gt; 1.4%, p&amp;lt;0.001), intensive care unit admission of mother (42.8% &lt;em&gt;vs.&lt;/em&gt; 0.2%, p&amp;lt;0.001), duration of hospitalization (7.52&amp;plusmn;6.34 &lt;em&gt;vs.&lt;/em&gt; 1.97&amp;plusmn;1.83, p&amp;lt;0.001), preterm birth &amp;lt;37 weeks (61.4% &lt;em&gt;vs.&lt;/em&gt; 16.8%, p&amp;lt;0.001), and perinatal mortality (7.4% vs. 1.8%, p&amp;lt;0.001) which manifested statistically significant values.&lt;br /&gt;
Conclusion: The frequency of PAS is similar to other populations.&amp;nbsp; Prior cesarean delivery, placenta previa, multigravidity, and multiparity were independent risk factors and also perinatal hysterectomy and preterm birth were the most important complications.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cesarean delivery, Placenta accreta spectrum, Placenta previa,  Endometrium</keyword>
	<start_page>279</start_page>
	<end_page>288</end_page>
	<web_url>https://www.jri.ir/article/140165</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/140165.pdf</pdf_url>
	<author_list><author><first_name>Mitra</first_name><middle_name></middle_name><last_name>Tadayon</last_name><suffix></suffix><affiliation>Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122453</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Nahid</first_name><middle_name></middle_name><last_name>Javadifar</last_name><suffix></suffix><affiliation>Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email>nahidjavadifar_341@yahoo. com,  Javadifar–n@ajums.ac.ir</email><code>122454</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Maryam</first_name><middle_name></middle_name><last_name>Dastoorpoor</last_name><suffix></suffix><affiliation>Department of Epidemiology, Menopause-Andropause Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122455</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Nahid</first_name><middle_name></middle_name><last_name>Shahbazian</last_name><suffix></suffix><affiliation>Fertility, Infertility, and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122456</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

